Nicole Scobie

发表

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

K. Norga, D. Faller, G. Vassal, 2020, European journal of cancer.

Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

S. Knudsen, Martha Donoghue, G. Vassal, 2022, European journal of cancer.

ACCELERATE - Five years accelerating cancer drug development for children and adolescents.

P. Kearns, G. Vassal, P. Adamson, 2022, European journal of cancer.

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.

W. Klapper, K. Norga, B. Burkhardt, 2019, European journal of cancer.

ACCELERATE and EMA Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children Authors

W. Klapper, K. Norga, B. Burkhardt, 2019 .

Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer.

P. Kearns, G. Vassal, A. Pearson, 2017, European journal of cancer.

Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

Sara M. Federico, M. Kool, G. Vassal, 2023, European journal of cancer.

To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma

N. Scobie, Donna Ludwinski, Nicholas P Bird, 2022, Pediatric blood & cancer.

Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.

D. Juric, Martha Donoghue, L. Marshall, 2024, European journal of cancer.

Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.

A. Balduzzi, E. Jacoby, P. Blanc, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

A. Baruchel, Abraham I. Bassan, G. Vassal, 2021, European journal of cancer.

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.

K. Norga, K. Wilner, Martha Donoghue, 2021, European journal of cancer.

When Innovation and Commercialization Collide: A Patient Advocate View in Neuroblastoma.

N. Scobie, Leona Knox, N. Bird, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

G. Rossato, G. Vassal, O. Witt, 2022, European journal of cancer.